News and Views

Scientists create first semi-synthetic organism that stores and retrieves unnatural information

Research could lead to new molecules for medical therapies.

Scientists discover possible master switch for programming cancer immunotherapy

How do killer T cells “learn” to leave their home base and amass within specific tissues like the skin, gut, and lung, or solid tumors?

New study sheds light on brain changes facilitating cocaine addiction

A collaboration from the Contet Lab reveals how two distinct brain regions can control drug use.

Taurine lends hand to repair cells damaged in multiple sclerosis

The Lairson and Siuzdak labs focus on a metabolite’s role in the nervous system.

Eric Topol named executive vice president at The Scripps Research Institute

“Eric is an esteemed colleague with a clear vision for integrating scientific discovery and translational medicine,” says TSRI President Peter Schultz.

Jeffery Kelly elected to National Academy of Inventors

The honor recognizes Kelly’s contributions as an academic researcher.

Ardem Patapoutian receives prestigious W. Alden Spencer Award

TSRI chemist Matthew Disney receives Israel Chemical Society’s Barry Cohen Award

New Chemistry Method Simplifies Late-Stage Modification of Drug Compounds
Good Cells Gone Bad
New Painkillers Reduce Overdose Risk
A Structural Clue to Attacking Malaria’s ‘Achilles Heel’
How Flu Shot Manufacturing Forces Influenza to Mutate
'Missing Link' in Chemistry That Led to Life on Earth
New Research Opens the Door to ‘Functional Cure’ for HIV
‘Double Decker’ Antibody Technology Fights Cancer
HIVE Center Receives $27 Million in NIGMS Funding to Advance HIV Research
Keary Engle Named TSRI Outstanding Mentor for 2017
TSRI Study Reveals New Clues to How a Successful HIV Vaccine Could Work
Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award

SEARCH NEWS & VIEWS